TELIX PHARMACEUTICALS Trademark

Trademark Overview

On Thursday, March 14, 2019, a trademark application was filed for TELIX PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the TELIX PHARMACEUTICALS trademark a serial number of 79257540. The federal status of this trademark filing is REGISTERED as of Tuesday, November 29, 2022. This trademark is owned by Telix Pharmaceuticals Limited. The TELIX PHARMACEUTICALS trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Apparatus for administering pharmaceuticals for the treatment, prevention, or diagnosis of cancer, namely, medical apparatus for introducing pharmaceutical preparations into the human body for the treatment, prevention, or diagnosis of cancer; apparatus for medical purposes for the treatment, prevention, or diagnosis of cancer, namely, injection needles, injection syringes, and radiological apparatus for the treatment, prevention, or diagnosis of cancer; medical apparatus for the treatment of cancer; imaging apparatus for medical use for diagnosing cancer; drug delivery systems for the treatment, prevention, or diagnosis of cancer, namely, applicators for pharmaceutical preparations sold without medication for use in the treatment, prevention, or diagnosis of cancer

Chemicals for pharmaceutical use for the treatment, prevention, or diagnosis of cancer; pharmaceutical drugs for the treatment, prevention, or diagnosis of cancer; pharmaceutical preparations for the treatment of cancer; radiopharmaceutical products for use in the treatment, prevention, or diagnosis of cancer
telix pharmaceuticals

General Information

Serial Number79257540
Word MarkTELIX PHARMACEUTICALS
Filing DateThursday, March 14, 2019
Status700 - REGISTERED
Status DateTuesday, November 29, 2022
Registration Number6908866
Registration DateTuesday, November 29, 2022
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 13, 2022

Trademark Statements

Goods and ServicesApparatus for administering pharmaceuticals for the treatment, prevention, or diagnosis of cancer, namely, medical apparatus for introducing pharmaceutical preparations into the human body for the treatment, prevention, or diagnosis of cancer; apparatus for medical purposes for the treatment, prevention, or diagnosis of cancer, namely, injection needles, injection syringes, and radiological apparatus for the treatment, prevention, or diagnosis of cancer; medical apparatus for the treatment of cancer; imaging apparatus for medical use for diagnosing cancer; drug delivery systems for the treatment, prevention, or diagnosis of cancer, namely, applicators for pharmaceutical preparations sold without medication for use in the treatment, prevention, or diagnosis of cancer
Goods and ServicesChemicals for pharmaceutical use for the treatment, prevention, or diagnosis of cancer; pharmaceutical drugs for the treatment, prevention, or diagnosis of cancer; pharmaceutical preparations for the treatment of cancer; radiopharmaceutical products for use in the treatment, prevention, or diagnosis of cancer
NOT AVAILABLE"PHARMACEUTICALS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 9, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, May 9, 2019
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTelix Pharmaceuticals Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressAU
Party NameTelix Pharmaceuticals Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressAU
Party NameTelix Pharmaceuticals Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressAU

Trademark Events

Event DateEvent Description
Thursday, April 25, 2019SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Wednesday, May 8, 2019LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, May 9, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 14, 2019APPLICATION FILING RECEIPT MAILED
Thursday, May 23, 2019ASSIGNED TO EXAMINER
Wednesday, May 29, 2019NON-FINAL ACTION WRITTEN
Thursday, May 30, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, June 14, 2019REFUSAL PROCESSED BY MPU
Friday, June 14, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, July 12, 2019REFUSAL PROCESSED BY IB
Friday, December 13, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, December 13, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 13, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 10, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Sunday, January 12, 2020NON-FINAL ACTION WRITTEN
Sunday, January 12, 2020NON-FINAL ACTION E-MAILED
Sunday, January 12, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 13, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 13, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 13, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 17, 2020NON-FINAL ACTION WRITTEN
Monday, August 17, 2020NON-FINAL ACTION E-MAILED
Monday, August 17, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 30, 2020NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, September 30, 2020NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Saturday, October 17, 2020NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, February 17, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 17, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 18, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 12, 2021FINAL REFUSAL WRITTEN
Friday, March 12, 2021FINAL REFUSAL E-MAILED
Friday, March 12, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Saturday, July 31, 2021LIMITATION OF GOODS RECEIVED FROM IB
Sunday, August 15, 2021LIMITATION OF GOODS/SERVICES FROM IB ENTERED
Monday, August 23, 2021TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, August 23, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 24, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, October 3, 2021LIMITATION OF GOODS RECEIVED FROM IB
Tuesday, August 9, 2022LIMITATION OF GOODS/SERVICES FROM IB ENTERED
Tuesday, August 9, 2022LIMITATION FROM THE IB - REQUEST EXAM REVIEW
Wednesday, August 10, 2022EXAMINERS AMENDMENT -WRITTEN
Wednesday, August 10, 2022EXAMINERS AMENDMENT E-MAILED
Wednesday, August 10, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, August 10, 2022EXAMINER'S AMENDMENT ENTERED
Wednesday, August 10, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, August 15, 2022NEW REPRESENTATIVE AT IB RECEIVED
Wednesday, August 24, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, August 24, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, August 24, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sunday, September 11, 2022NOTIFICATION PROCESSED BY IB
Tuesday, September 13, 2022PUBLISHED FOR OPPOSITION
Tuesday, September 13, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 29, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, November 29, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, February 28, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, March 16, 2023FINAL DISPOSITION PROCESSED
Thursday, March 16, 2023FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, April 19, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, February 26, 2026NEW REPRESENTATIVE AT IB RECEIVED

Related Keywords

pharmaceuticals telix cancer treatment diagnosis prevention apparatus pharmaceutical medical namely preparations injection